{"id":"W4307852697","doi":"10.1007/s12325-022-02322-y","title":"No Increased Risk of Overall Infection in Adults with Moderate-to-Severe Atopic Dermatitis Treated for up to 4 Years with Dupilumab","year":2022,"lang":"en","type":"article","venue":"Advances in Therapy","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"LEO Pharma; Eli Lilly and Company; Ortho Dermatologics; Galderma; Incyte; Dermira; Les Laboratories Pierre Fabre; UCB Pharma; Sun Pharma; Regeneron Pharmaceuticals; Valeant Pharmaceuticals International; Sanofi; Amgen; Pfizer","keywords":"Medicine; Dupilumab; Atopic dermatitis; Discontinuation; Incidence (geometry); Placebo; Dosing; Internal medicine; Adverse effect; Regimen; Cumulative incidence; Dermatology; Cohort","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001002267,0.0002666154,0.0005216467,0.0002264721,0.0002298196,0.0004762741,0.0001396469,0.0004491943,0.001240977],"category_scores_gemma":[0.001727795,0.0001782987,0.0009726667,0.0002542921,0.000148359,0.0002990789,0.0003515137,0.0006857056,0.0001198216],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001884362,"about_ca_system_score_gemma":0.0003028466,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001059384,"about_ca_topic_score_gemma":0.002191266,"domain_scores_codex":[0.9990098,0.0003835608,0.0001052163,0.0001585954,0.0002160863,0.0001268052],"domain_scores_gemma":[0.9982606,0.0002966669,0.0009476182,0.0001178394,0.0001488654,0.0002284023],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009406864,0.0002988816,0.9634709,0.000171724,0.0005680546,0.0003897568,0.0001080011,0.0001208048,0.002204564,0.00004933689,0.0004734669,0.02273765],"study_design_scores_gemma":[0.0003252219,0.00451271,0.9921756,0.00004775315,0.0003777124,0.001115901,0.00006866407,0.0002150642,0.0003236585,0.00003208145,0.000794159,0.00001141],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955046,0.002958172,0.000119178,0.00005387831,0.00001539281,0.0000274837,0.0002448932,0.000006980731,0.001069503],"genre_scores_gemma":[0.9988644,0.0004797148,0.00009389288,0.00009043491,0.00002304012,0.00001286143,0.000214104,0.000001511612,0.0002200778],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001240977,"threshold_uncertainty_score":0.005300581,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005435478724070912,"score_gpt":0.2544706578341253,"score_spread":0.2490351791100543,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}